In a reflection of the company’s continued growth both domestically and abroad, Fisher Adams Kelly is delighted to announce the recent promotions of Dr Declan McKeveney to Principal, and Fraser Smith to Associate.
In seven years with Fisher Adams Kelly, Declan has practised in all areas of chemistry, with a particular focus on innovations in nanotechnology, pharmaceutical compounds and drug delivery technologies. Prior to this Declan worked as a research scientist for a Queensland biotechnology company, and was recognised as the creator of intellectual property used to target a variety of disease processes. He has consistently used this real world experience of cutting edge R&D to provide water-tight protection for clients across the chemical industries.
Fraser comes originally from New Zealand, where he was instrumental in developing a successful commercialization project for a start up incubator company. With international post-graduate qualifications in electrical engineering and industrial property, and extensive experience as a registered patent attorney, Fraser has developed an acute understanding of the competitive edge that proprietary technology and innovation affords his clients.
We are very pleased to be able to continue our commitment to our attorney’s professional development, and to recognising the important contribution that they make to our clients’ success. For a free initial consultation with Declan, Fraser, or any of our qualified patent attorneys in Brisbane contact us on +61 7 3229 2655.